Intrinsic Value of S&P & Nasdaq Contact Us

Personalis, Inc. PSNL NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
56/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.25
+68.4%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Personalis, Inc. (PSNL) has a negative trailing P/E of -6.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -15.11%.

Criteria proven by this page:

  • VALUE (88/100, Pass) — analyst target implies upside (+68.4%).
  • Trailing Earnings Yield -15.11% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $11.25 (+68.4% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 55/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
56/100
SG Score
View full scorecard →
VALUE
88/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
42/100
→ Income
~
GROWTH
40/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — PSNL

Valuation Multiples
P/E (TTM)-6.6
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio2.06
P/S Ratio7.43
EV/EBITDA-6.0
Per Share Data
EPS (TTM)$-0.88
Book Value / Share$2.83
Revenue / Share$0.75
FCF / Share$-0.86
Yields & Fair Value
Earnings Yield-15.11%
Dividend Yield0.00%
Analyst Target$11.25 (+68.4%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2017 -26.3 0.00 -6.69 65.98 -
2018 -31.2 1.98 -5.83 16.41 -
2019 -7.8 -0.15 1.84 3.01 -
2020 -30.5 2.23 6.46 16.00 -
2021 -9.6 -0.40 2.02 7.33 -
2022 -0.8 -0.01 0.41 1.39 -
2023 -0.9 0.10 0.78 1.38 -
2024 -4.2 0.11 1.69 4.05 -
2025 -8.7 0.26 2.72 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2017 $-1.08 $9.39M $-23.6M -251.2%
2018 $-0.91 $37.77M $-19.89M -52.6%
2019 $-0.80 $65.21M $-25.08M -38.5%
2020 $-1.06 $78.65M $-41.28M -52.5%
2021 $-1.49 $85.49M $-65.23M -76.3%
2022 $-2.48 $65.05M $-113.32M -174.2%
2023 $-2.25 $73.48M $-108.3M -147.4%
2024 $-1.37 $84.61M $-81.28M -96.1%
2025 $-0.91 $0.00 $-81.27M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.08 $-1.12 – $-1.02 $78.84M $78.51M – $79.19M 4
2027 $-0.94 $-0.98 – $-0.89 $109.79M $106.74M – $112.84M 4
2028 $-0.53 $-0.55 – $-0.51 $158.68M $158.68M – $158.68M 2
2029 $-0.13 $-0.14 – $-0.12 $180.9M $173.9M – $186.35M 1
2030 $-0.02 $-0.02 – $-0.02 $222.9M $214.28M – $229.61M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message